{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:21:27Z","timestamp":1772306487607,"version":"3.50.1"},"reference-count":30,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1248\/bpb.b14-00469","type":"journal-article","created":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T22:05:39Z","timestamp":1422741939000},"page":"193-200","source":"Crossref","is-referenced-by-count":8,"title":["The Kampo Medicine Daikenchuto Inhibits Peritoneal Fibrosis in Mice"],"prefix":"10.1248","volume":"38","author":[{"given":"Mineaki","family":"Kitamura","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Nishino","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Obata","sequence":"additional","affiliation":[{"name":"Medical Education Development Center, Nagasaki University Hospital"},{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Oka","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Abe","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Muta","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ozono","sequence":"additional","affiliation":[{"name":"Department of General medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Koji","sequence":"additional","affiliation":[{"name":"Department of Histology and Cell Biology, Unit of Basic Medical Science, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT, Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. <i>J. Am. Soc. Nephrol.<\/i>, <b>13<\/b>, 470\u2013479 (2002).","DOI":"10.1681\/ASN.V132470"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hoff CM. Experimental animal models of encapsulating peritoneal sclerosis. <i>Perit. Dial. Int.<\/i>, <b>25<\/b> (Suppl. 4), S57\u2013S66 (2005).","DOI":"10.1177\/089686080502504S08"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. <i>Perit. Dial. Int.<\/i>, <b>23<\/b>, 530\u2013541 (2003).","DOI":"10.1177\/089686080302300604"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Lo WK, Kawanishi H. Encapsulating peritoneal sclerosis\u2014medical and surgical treatment. <i>Perit. Dial. Int.<\/i>, <b>29<\/b> (Suppl. 2), S211\u2013S214 (2009).","DOI":"10.1177\/089686080902902S43"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Gandhi VC, Humayun HM, Ing TS, Daugirdas JT, Jablokow VR, Iwatsuki S, Geis WP, Hano JE. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. <i>Arch. Intern. Med.<\/i>, <b>140<\/b>, 1201\u20131203 (1980).","DOI":"10.1001\/archinte.1980.00330200077024"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Braun N, Fritz P, Biegger D, Kimmel M, Reimold F, Ulmer C, Alscher MD. Difference in the expression of hormone receptors and fibrotic markers in the human peritoneum\u2014implications for therapeutic targets to prevent encapsulating peritoneal sclerosis. <i>Perit. Dial. Int.<\/i>, <b>31<\/b>, 291\u2013300 (2011).","DOI":"10.3747\/pdi.2010.00118"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Manabe N, Camilleri M, Rao A, Wong BS, Burton D, Busciglio I, Zinsmeister AR, Haruma K. Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. <i>Am. J. Physiol. Gastrointest. Liver Physiol.<\/i>, <b>298<\/b>, G970\u2013G975 (2010).","DOI":"10.1152\/ajpgi.00043.2010"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Munekage M, Kitagawa H, Ichikawa K, Watanabe J, Aoki K, Kono T, Hanazaki K. Pharmacokinetics of daikenchuto, a traditional Japanese medicine (Kampo) after single oral administration to healthy Japanese volunteers. <i>Drug Metab. Dispos.<\/i>, <b>39<\/b>, 1784\u20131788 (2011).","DOI":"10.1124\/dmd.111.040097"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Narita M, Hatano E, Tamaki N, Yamanaka K, Yanagida A, Nagata H, Asechi H, Takada Y, Ikai I, Uemoto S. Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver. <i>J. Gastroenterol. Hepatol.<\/i>, <b>24<\/b>, 1051\u20131057 (2009).","DOI":"10.1111\/j.1440-1746.2009.05795.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kono T, Omiya Y, Hira Y, Kaneko A, Chiba S, Suzuki T, Noguchi M, Watanabe T. Daikenchuto (TU-100) ameliorates colon microvascular dysfunction <i>via<\/i> endogenous adrenomedullin in Crohn\u2019s disease rat model. <i>J. Gastroenterol.<\/i>, <b>46<\/b>, 1187\u20131196 (2011).","DOI":"10.1007\/s00535-011-0438-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kono T, Kaneko A, Hira Y, Suzuki T, Chisato N, Ohtake N, Miura N, Watanabe T. Anti-colitis and -adhesion effects of daikenchuto <i>via<\/i> endogenous adrenomedullin enhancement in Crohn\u2019s disease mouse model. <i>J. Crohns Colitis<\/i>, <b>4<\/b>, 161\u2013170 (2010).","DOI":"10.1016\/j.crohns.2009.09.006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Inoue K, Naito Y, Takagi T, Hayashi N, Hirai Y, Mizushima K, Horie R, Fukumoto K, Yamada S, Harusato A, Hirata I, Omatsu T, Yoshida N, Uchiyama K, Ishikawa T, Handa O, Konishi H, Wakabayashi N, Yagi N, Ichikawa H, Kokura S, Yoshikawa T. Daikenchuto, a Kampo medicine, regulates intestinal fibrosis associated with decreasing expression of heat shock protein 47 and collagen content in a rat colitis model. <i>Biol. Pharm. Bull.<\/i>, <b>34<\/b>, 1659\u20131665 (2011).","DOI":"10.1248\/bpb.34.1659"},{"key":"13","unstructured":"13) Razzaque MS, Taguchi T. The possible role of colligin\/HSP47, a collagen-binding protein, in the pathogenesis of human and experimental fibrotic diseases. <i>Histol. Histopathol.<\/i>, <b>14<\/b>, 1199\u20131212 (1999)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Razzaque MS, Le VT, Taguchi T. Heat shock protein 47 and renal fibrogenesis. <i>Contrib. Nephrol.<\/i>, <b>148<\/b>, 57\u201369 (2005).","DOI":"10.1159\/000086043"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Shioshita K, Miyazaki M, Ozono Y, Abe K, Taura K, Harada T, Koji T, Taguchi T, Kohno S. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis. <i>Kidney Int.<\/i>, <b>57<\/b>, 619\u2013631 (2000).","DOI":"10.1046\/j.1523-1755.2000.00883.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tokita Y, Yamamoto M, Satoh K, Nishiyama M, Iizuka S, Imamura S, Kase Y. Possible involvement of the transient receptor potential vanilloid type 1 channel in postoperative adhesive obstruction and its prevention by a Kampo (traditional Japanese) medicine, daikenchuto. <i>J. Pharmacol. Sci.<\/i>, <b>115<\/b>, 75\u201383 (2011).","DOI":"10.1254\/jphs.10226FP"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Mishima Y, Miyazaki M, Abe K, Ozono Y, Shioshita K, Xia Z, Harada T, Taguchi T, Koji T, Kohno S. Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis. <i>Perit. Dial. Int.<\/i>, <b>23<\/b>, 14\u201322 (2003).","DOI":"10.1177\/089686080302300102"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nishino T, Miyazaki M, Abe K, Furusu A, Mishima Y, Harada T, Ozono Y, Koji T, Kohno S. Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. <i>Kidney Int.<\/i>, <b>64<\/b>, 887\u2013896 (2003).","DOI":"10.1046\/j.1523-1755.2003.00169.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Song N, Liu J, An S, Nishino T, Hishikawa Y, Koji T. Immunohistochemical analysis of histone H3 modifications in germ cells during mouse spermatogenesis. <i>Acta Histochem. Cytochem.<\/i>, <b>44<\/b>, 183\u2013190 (2011).","DOI":"10.1267\/ahc.11027"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Yoshio Y, Miyazaki M, Abe K, Nishino T, Furusu A, Mizuta Y, Harada T, Ozono Y, Koji T, Kohno S. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. <i>Kidney Int.<\/i>, <b>66<\/b>, 1677\u20131685 (2004).","DOI":"10.1111\/j.1523-1755.2004.00935.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kitamura M, Nishino T, Obata Y, Furusu A, Hishikawa Y, Koji T, Kohno S. Epigallocatechin gallate suppresses peritoneal fibrosis in mice. <i>Chem. Biol. Interact.<\/i>, <b>195<\/b>, 95\u2013104 (2012).","DOI":"10.1016\/j.cbi.2011.11.002"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) De Vriese AS, Tilton RG, Mortier S, Lameire NH. Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. <i>Nephrol. Dial. Transplant.<\/i>, <b>21<\/b>, 2549\u20132555 (2006).","DOI":"10.1093\/ndt\/gfl271"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Tokita Y, Yuzurihara M, Sakaguchi M, Satoh K, Kase Y. The pharmacological effects of Daikenchuto, a traditional herbal medicine, on delayed gastrointestinal transit in rat postoperative ileus. <i>J. Pharmacol. Sci.<\/i>, <b>104<\/b>, 303\u2013310 (2007).","DOI":"10.1254\/jphs.FP0070831"},{"key":"24","unstructured":"24) Takagi A, Yagi M, Tanaka Y, Asagiri K, Asakawa T, Tanaka H, Ishii S, Egami H, Akaiwa M, Tsuru T. The herbal medicine daikenchuto ameliorates an impaired anorectal motor activity in postoperative pediatric patients with an anorectal malformation\u2014a pilot study. <i>Int. Surg.<\/i>, <b>95<\/b>, 350\u2013355 (2010)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Mochiki E, Yanai M, Ohno T, Kuwano H. The effect of traditional Japanese medicine (Kampo) on gastrointestinal function. <i>Surg. Today<\/i>, <b>40<\/b>, 1105\u20131111 (2010).","DOI":"10.1007\/s00595-010-4388-8"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Akiho H, Nakamura K. Daikenchuto ameliorates muscle hypercontractility in a murine T-cell-mediated persistent gut motor dysfunction model. <i>Digestion<\/i>, <b>83<\/b>, 173\u2013179 (2011).","DOI":"10.1159\/000321798"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Tokita Y, Satoh K, Sakaguchi M, Endoh Y, Mori I, Yuzurihara M, Sakakibara I, Kase Y, Takeda S, Sasaki H. The preventive effect of Daikenchuto on postoperative adhesion-induced intestinal obstruction in rats. <i>Inflammopharmacology<\/i>, <b>15<\/b>, 65\u201366 (2007).","DOI":"10.1007\/s10787-006-1552-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Murata P, Kase Y, Ishige A, Sasaki H, Kurosawa S, Nakamura T. The herbal medicine Dai-kenchu-to and one of its active components [6]-shogaol increase intestinal blood flow in rats. <i>Life Sci.<\/i>, <b>70<\/b>, 2061\u20132070 (2002).","DOI":"10.1016\/S0024-3205(01)01552-1"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nievergelt A, Marazzi J, Schoop R, Altmann KH, Gertsch J. Ginger phenylpropanoids inhibit IL-1beta and prostanoid secretion and disrupt arachidonate-phospholipid remodeling by targeting phospholipases A2. <i>J. Immunol.<\/i>, <b>187<\/b>, 4140\u20134150 (2011).","DOI":"10.4049\/jimmunol.1100880"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Isa Y, Miyakawa Y, Yanagisawa M, Goto T, Kang MS, Kawada T, Morimitsu Y, Kubota K, Tsuda T. 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-alpha mediated downregulation of adiponectin expression <i>via<\/i> different mechanisms in 3T3-L1 adipocytes. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>373<\/b>, 429\u2013434 (2008).","DOI":"10.1016\/j.bbrc.2008.06.046"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/38\/2\/38_b14-00469\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T03:21:46Z","timestamp":1651116106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/38\/2\/38_b14-00469\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b14-00469","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}